Consistent with these findings, a previous study has demonstrated that RAMP2-AS1 expression is significantly decreased in primary glioblastoma tissues compared with in normal brain tissues and that its decreased expression levels are associated with poor OS in patients with glioblastoma (33). This evidence concerns the gene RAMP2 and glioblastoma.